Related Experiment Video
Updated: Sep 21, 2025

Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
Idiopathic Pleuroparenchymal Fibroelastosis
Kameron Tavakolian1, Ndausung Udongwo1, Steven Douedi1
1Department of Medicine, Jersey Shore University Medical Center, Neptune City, NJ, USA.
Abstract:
Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare form of idiopathic interstitial pneumonia. The disease is characterized by fibrosis of the pleura and subpleural lung parenchyma predominantly affecting the upper lobes. Various triggers have been proposed as inciting factors in the development of the disease. Diagnosis is made clinically in conjunction with radiographic findings and histopathology when available. There are no known effective treatment options and several cases of lung transplantation have been reported. We report a case of an 86-year-old female who presented to the emergency department with worsening dyspnea and hypoxia. She had a history of unexplained pneumomediastinum and a 20 - 25 pounds unintentional weight loss over 10 months. Computed tomography (CT) of the chest without contrast revealed radiographic evidence of IPPFE. Despite symptomatic management with antibiotics, diuretics, and steroids, her condition continued to deteriorate. Unfortunately, our patient was not a candidate for a lung transplant. She was transitioned to hospice care and succumbed to her disease. IPPFE is a rare disease with an unknown prevalence. It has a median survival rate of 2 years. Usually, there is an overlap with interstitial lung diseases, making it challenging to diagnose. There are only a few cases reported in the literature, and there are currently no guidelines available on the appropriate management of this debilitating disease. We recommend more cases be reported, and further research is done to establish better criteria for diagnosis and management.
Insights
Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare lung disease. This case report highlights diagnostic challenges and the lack of effective treatments for IPPFE, emphasizing the need for further research.
Area of Science:
- Pulmonology
- Radiology
- Pathology
Background:
- Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare idiopathic interstitial pneumonia.
- It affects the pleura and subpleural lung parenchyma, predominantly in the upper lobes.
- Diagnosis relies on clinical, radiographic, and histopathological findings.
Observation:
- An 86-year-old female presented with dyspnea and hypoxia.
- She had a history of pneumomediastinum and unintentional weight loss.
- Chest CT confirmed radiographic evidence of IPPFE.
Findings:
- Standard treatments including antibiotics, diuretics, and steroids were ineffective.
- The patient's condition deteriorated, and she was transitioned to hospice care.
- IPPFE has a median survival of 2 years and often overlaps with other interstitial lung diseases.
Implications:
- IPPFE is challenging to diagnose due to overlapping features with other interstitial lung diseases.
- There are no established treatment guidelines for IPPFE.
- Further research and case reporting are crucial for improved diagnosis and management strategies.
Related Concept Videos
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleural Disorders: Types and Brief Description
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pleura of the Lungs
Cardiomyopathy IV: Restrictive Cardiomyopathy

